The impact of a high fine particle fraction inhaled long acting ß2 agonist (Formoterol) on airway function in asthma: evaluation with oxygen enhanced MRI and multiple breath washout.

M. Soares (LEICESTER, United Kingdom)

Source: International Congress 2017 – Imaging markers for COPD and asthma
Session: Imaging markers for COPD and asthma
Session type: Thematic Poster
Number: 801
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Soares (LEICESTER, United Kingdom). The impact of a high fine particle fraction inhaled long acting ß2 agonist (Formoterol) on airway function in asthma: evaluation with oxygen enhanced MRI and multiple breath washout.. 801

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The suitability of exhaled breath compounds to identify children with exercise induced bronchoconstriction is modulated by the use of inhaled corticosteroids.
Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics
Year: 2019

Effect of an inhaled short acting beta agonist on exhaled breath temperature
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010


Effects of low dose inhaled theophylline (ADC4022) co-administered with budesonide on inflammatory markers, lung function, and quality of life in COPD patients
Source: Annual Congress 2009 - New drugs for airways disease
Year: 2009


Effect of inhaled corticosteroid on air trapping in asthma: a CT scan approach
Source: Eur Respir J 2004; 24: Suppl. 48, 68s
Year: 2004

Influence of formoterol alone and its fixed combination with budesonide on airway responsiveness and airway inflammation induced by repeated low dose allergen challenge
Source: Eur Respir J 2007; 30: Suppl. 51, 749s
Year: 2007

Combination of inhaled corticosteroids and long acting beta two agonists improve lung clearance index (LCI) in preschoolers with cystic fibrosis
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011


Effects of montelukast vs. placebo on small airways function: assessment using functional HRCT and physiologic measures
Source: Eur Respir J 2003; 22: Suppl. 45, 102s
Year: 2003

Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 261s
Year: 2001

Effects of inhaled saline and oxygen on noninvasive markers of airway and lung function
Source: Annual Congress 2012 - New insights in the clinical management of lung diseases
Year: 2012

Effect of switching from high-dose inhaled corticosteroid (ICS) to low-dose ICS plus an inhaled long-acting β2-agonist on asthma control, airway inflammation and remodeling, and gene expression in airway epithelial cells
Source: Eur Respir J 2003; 22: Suppl. 45, 35s
Year: 2003

Monitoring asthma and adjusting the inhaled steroid dose: is there a better way?
Source: Annual Congress 2005 - Are we ready for "inflammometry"? The role of eNO in asthma management
Year: 2005

The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation
Source: Eur Respir J 2005; 26: Suppl. 49, 503s
Year: 2005

Airway calibre variability by forced oscillation technique: a sensitive indicator of bronchodilator effect in asthmatic children
Source: Annual Congress 2005 - Monitoring paediatric asthma
Year: 2005


Respiratory muscle strength after inhaled short acting beta-agonist administration in stable COPD patients
Source: Annual Congress 2012 - Mechanics, muscles and movement: aspects of airway mechanics, repiratory muscle assessment and field exercise tests
Year: 2012

Sputum eosinophil counts in a large population of mild-to-moderate asthmatics: distribution, relationship with methacholine bronchial responsiveness and influence of a regular treatment with low doses of inhaled corticosteroids
Source: Eur Respir J 2001; 18: Suppl. 33, 531s
Year: 2001

Reversing acute bronchoconstriction in asthma: the effect of bronchodilator tolerance after treatment with formoterol
Source: Eur Respir J 2001; 17: 368-373
Year: 2001



In-vitro emitted dose characteristics of combination budesonide / formoterol tubuhaler using patient inhalation profiles
Source: International Congress 2015 – Lung function: waiting to exhale...
Year: 2015


Short-acting beta-agonist (SABA) and airway inflammation: dynamic negative interaction
Source: Eur Respir J 2002; 20: Suppl. 38, 110s
Year: 2002

Effect of inhaled beta2 agonist on lung compliance in patients with COPD with poor bronchodilator response
Source: Eur Respir J 2006; 28: Suppl. 50, 428s
Year: 2006

Mechanism of protective effect of inhaled budesonide on airway response to ozone (O3) exposure
Source: Eur Respir J 2004; 24: Suppl. 48, 364s
Year: 2004